Product
Investigational MMRV(H)NS vaccine
1 clinical trial
1 indication
Indication
MeaslesClinical trial
A Phase II, Single-blind, Randomized, Controlled Study to Evaluate the Immunogenicity and Safety of a Measles, Mumps, Rubella, Varicella Vaccine Compared With ProQuad, Administered in Healthy Children 4-6 Years of AgeStatus: Active (not recruiting), Estimated PCD: 2024-06-04